Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Insan Farmasi Indonesia
Mexsi Mutia Rissa
Program Studi Diploma III Farmasi, Akademi Farmasi Indonesia Yogyakarta, Indonesia
Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology Physics

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ANALISIS HUBUNGAN TINGKAT KEPATUHAN PENGGUNAAN OBAT TERHADAP KUALITAS HIDUP PASIEN DIABETES MELLITUS TIPE II DI PUSKESMAS BAMBANGLIPURO BANTUL Mexsi Mutia Rissa; Machfudz Eko Arianto
Jurnal Insan Farmasi Indonesia Vol 9 No 1 (2026): Jurnal Insan Farmasi Indonesia
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/4678wd55

Abstract

Diabetes Mellitus is a degenerative disease that requires long-term management. Medication adherence plays an important role in treatment success, as it can influence the quality of life in patients with Type II Diabetes Mellitus. This study aimed to determine the relationship between medication adherence and quality of life among Type II Diabetes Mellitus patients at Bambanglipuro Primary Health Center, Bantul. This study used an analytical observational design with a cross-sectional approach. A total of 52 patients were included using total sampling technique. Medication adherence was measured using the Morisky Medication Adherence Scale (MMAS-8), while quality of life was assessed using the Short Form-36 (SF-36). Data were analyzed using the Chi-Square test. The results showed that most respondents had high medication adherence (86.54%) and good quality of life across most domains. The Chi-Square test showed a significance value of p = 0.000 (p < 0.05), indicating a significant relationship between medication adherence and quality of life. In conclusion, there is a significant relationship between medication adherence and quality of life in patients with Type II Diabetes Mellitus.
Co-Authors Machfudz Eko Arianto